Mar­ket­ingRx roundup: CVS amps Mod­er­na’s CMV vac­cine tri­al; An­oth­er star in Pfiz­er’s Covid vac­ci­na­tion sky

One of Mod­er­na’s clin­i­cal tri­al part­ners for its cy­tomegalovirus (CMV) vac­cine study is CVS health through its clin­i­cal tri­als busi­ness launched in 2021. And now CVS is help­ing to dri­ve aware­ness of the tri­al in emails to its cus­tomers.

A re­cent email of­fered an in­vi­ta­tion to “team up with Mod­er­na to stop the spread of CMV (and0 par­tic­i­pate in Mod­er­na’s CMVic­to­ry Tri­al, a clin­i­cal re­search tri­al for an in­ves­ti­ga­tion­al vac­cine that may pro­tect against Cy­tomegalovirus (CMV) in­fec­tion.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER